Healthcare professionals give pharma company engagements middle-of-the-road reviews in a new survey. (Image: Shutterstock)

UCB, No­vo Nordisk, Gilead rank high­est among phar­mas for HCP cus­tomer ex­pe­ri­ence — sur­vey

When it comes to cus­tomer ser­vice to health­care pro­fes­sion­als, phar­ma com­pa­nies’ over­all av­er­age rat­ing is, well, av­er­age. Its in­dus­try cus­tomer ex­pe­ri­ence score of 59 is at the low­er end of “good” (rat­ed as scores from 51-75) in DT Con­sult­ing’s an­nu­al as­sess­ment out now.

Top­ping the list of in­di­vid­ual phar­ma com­pa­nies was UCB with a 66 score on the con­sul­tant’s pro­pri­etary “Cus­tomer Ex­pe­ri­ence Quo­tient” or CXQ scale. No­vo Nordisk and Gilead Sci­ences fol­lowed, tied for sec­ond at 65, while Boehringer In­gel­heim and John­son & John­son’s Janssen tied for third with 64. Still, none of the top scores neared “ex­cel­lent” ter­ri­to­ry of 76 or high­er.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.